£31.0M
The Series B round was led by Northpond Ventures to support international growth.
"It’s rare to see a company successfully execute across both healthcare delivery and drug delivery – this is what makes Current Health so special"
Portfolio
1
companies
The Series B round was led by Northpond Ventures to support international growth.
"It’s rare to see a company successfully execute across both healthcare delivery and drug delivery – this is what makes Current Health so special"